3-碘-1H-吲哚-2-甲酸甲酯 | 534595-85-2

• 物质功能分类: 医药中间体
• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吲哚及其衍生物
• 中文名称: 3-碘-1H-吲哚-2-甲酸甲酯
• 中文别名: 3-碘-1H-吲哚-2-羧酸甲酯
• 英文名称: methyl 3-iodo-1H-indole-2-carboxylate
• CAS: 534595-85-2
• 化学式: C₁₀H₈INO₂
• 分子量: 301.084
• InChiKey: PBUCSGICMRIPAA-UHFFFAOYSA-N

物化性质

• 熔点：
  157-159°C
• 沸点：
  392.3±22.0 °C(Predicted)
• 密度：
  1.860±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.9
• 重原子数：
  14
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.1
• 拓扑面积：
  42.1
• 氢给体数：
  1
• 氢受体数：
  2

安全信息

• 危险等级：
  IRRITANT
• 海关编码：
  2933990090
• 储存条件：
  | 室温 |

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: Methyl 3-iodo-1H-indole-2-carboxylate
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: Methyl 3-iodo-1H-indole-2-carboxylate
CAS number: 534595-85-2

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels, refrigerated.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C10H8INO2
Molecular weight: 301.1

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen Iodide.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  3-碘-1H-吲哚-2-甲酸甲酯 在 bis-triphenylphosphine-palladium(II) chloride 、 copper(l) iodide 、 水 、 三乙胺 、 potassium hydroxide 、 sodium hydroxide 作用下， 以 甲醇 、 乙醇 、 二甲基亚砜 为溶剂， 反应 13.5h， 生成
  参考文献：
  名称：

  柔性合成吡喃并吲哚酮并评估对HeLa细胞的细胞毒性

  摘要：

  一种杂化的药效基团合成方法，用于合成异构的吡喃并吲哚酮，是通过采用氯化金（III）催化炔烃系吲哚羧酸的环异构化反应来实现的，收率很好。所有合成的化合物对肿瘤细胞生长的抗人宫颈腺癌（HeLa细胞）的抑制活性，其表明三个化合物表现出的活性与标准比较的评价顺-platin（IC 50 = 0.08 μ M）。牛痘H1相关（VHR）磷酸酶受体中所有化合物的分子对接也支持该化合物7d最活泼，结合自由能为-8.27 kcal / mol。 通过AuCl 3催化乙炔系链的吲哚羧酸的6-内-挖-环异构化，以中等至良好的收率实现了高度区域选择性的吡喃并吲哚酮的合成。另外，评估了所有合成的化合物对人宫颈腺癌细胞的细胞毒性潜力。

  DOI：

  10.1007/s12039-016-1070-8
• 作为产物：
  描述：

  吲哚-2-羧酸甲酯 在 potassium hydroxide 、 碘 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 反应 3.25h， 生成 3-碘-1H-吲哚-2-甲酸甲酯
  参考文献：
  名称：

  氯化金（III）催化吡喃并[3,4- b ]吲哚-1（9 H）-酮的区域选择性合成及其对人宫颈腺癌的抗癌能力

  摘要：

  通过氯化金（III）催化3-乙炔基-吲哚-2-羧酸的环异构化，高度区域选择性地合成了吡喃并[3,4- b ]吲哚-1（9 H）-，得到了很好的收率。筛选这些化合物对人宫颈（HeLa）细胞系的体外细胞毒性。在十种化合物中，三种化合物（7d，7e和7j）显示出与标准药物顺铂相当的增殖抑制活性。发现化合物7d最有效，IC 50值为0.22μM。

  DOI：

  10.1016/j.bmcl.2011.05.088

文献信息

• Efficient Synthesis of the First N-Methyloxoarcyriaflavin Including an Original Central Seven-Membered Cycle
  作者：Sylvain Routier、Aurélie Bourderioux、Aziz Ouach、Valérie Bénéteau、Jean-Yves Mérour

  DOI：10.1055/s-0029-1218626

  日期：2010.3

  A new route to the first N-methyloxoarcyriaflavin was designed. The compound was obtained by a palladium-catalyzed Stille cross-coupling reaction, followed by an electrophilic cyclization onto a C-2 indolic position as a key step. indole - tropone - palladium - electrophilic cyclization - rearrangement

  设计了一条通往第一个N-甲基氧代草酰黄素的新途径。该化合物是通过钯催化的Stille交叉偶联反应，然后进行亲电环化到C-2吲哚位置上作为关键步骤而获得的。 吲哚-托酮-钯-亲电环化-重排
• Asymmetric Reductive Amination/Ring-Closing Cascade: Direct Synthesis of Enantioenriched Biaryl-Bridged NH Lactams
  作者：Yao Zhang、Yun-Qi Liu、Le’an Hu、Xumu Zhang、Qin Yin

  DOI：10.1021/acs.orglett.0c02282

  日期：2020.8.21

  here a Ru-catalyzed enantioselective synthesis of biaryl-bridged NH lactams through asymmetric reductive amination and a spontaneous ring-closing cascade from keto esters and NH4OAc with H2 as reductant. The reaction features broad substrate generality and high enantioselectivities (up to >99% ee). To showcase the practical utility, a highly enantioselective synthesis of 5-ethylindolobenzazepinone C, a

  我们在此报告了通过不对称还原胺化和酮酯和 NH 4 OAc 以 H 2作为还原剂的自发闭环级联反应，Ru 催化的对映选择性合成联芳基桥连 NH 内酰胺。该反应具有广泛的底物通用性和高对映选择性（高达> 99% ee）。为了展示实用性，快速完成了 5-乙基吲哚苯并氮杂酮C的高度对映选择性合成，这是一种很有前途的抗有丝分裂剂。此外，产品中的酰胺基团可以通过定向 C-H 功能化进行多种加工。
• Catalyst-Free Formal Thioboration to Synthesize Borylated Benzothiophenes and Dihydrothiophenes
  作者：Darius J. Faizi、Ashlee J. Davis、Fiach B. Meany、Suzanne A. Blum

  DOI：10.1002/anie.201608090

  日期：2016.11.7

  isolated prior to downstream functionalization. This methodology has been extended to the synthesis of borylated dihydrothiophenes. Mechanistic experiments suggest that the operative mechanistic pathway is through boron‐induced activation of the alkyne followed by electrophilic cyclization, as opposed to S−B σ bond formation, providing a mechanistically distinct pathway to the thioboration of C−C π bonds.

  据报道，第一个C-Cπ键成环的硫代硼烷基化反应。这种无催化剂的方法可以在市售的外部亲电硼源（B-氯邻苯二甲硼烷）存在下进行，产率很高。该方法是可扩展的，并且可以忍受其他主要的硼酸酯化方法所不能忍受的各种官能团。所得的硼化苯并噻吩参与各种原位衍生化反应，表明这些硼化的中间体无需在下游官能化之前分离。该方法已经扩展到硼酸化的二氢噻吩的合成。机理实验表明，与SBσ键形成相反，其作用机理是通过硼诱导的炔烃活化，然后进行亲电环化，
• [EN] INHIBITORS OF METALLO-BETA-LACTAMASES<br/>[FR] INHIBITEURS DE MÉTALLO-BÊTA-LACTAMASES
  申请人：UNIV OXFORD INNOVATION LTD

  公开号：WO2017093727A1

  公开（公告）日：2017-06-08

  The present invention relates to certain compounds, in particular, indole derivatives that function as inhibitors of bacterial metallo-beta- lactamases. The present invention also relates to processes for the preparation of these compounds, to pharmaceutical compositions comprising them, and to their use in the treatment of a bacterial infection.

  本发明涉及特定化合物，特别是吲哚衍生物，其作为细菌金属β-内酰胺酶的抑制剂。本发明还涉及制备这些化合物的方法，包括含有它们的药物组合物，以及它们在治疗细菌感染中的用途。
• New indole derivatives as factor Xa inhibitors
  申请人：——

  公开号：US20030199689A1

  公开（公告）日：2003-10-23

  The present invention relates to compounds of formula I, 1 in which R 0 ; R 1 ; R 2 ; R 3 ; R 4 ; R 5 ; R 6 ; R 7 ; Q; V, G and M have the meanings indicated in the claims. The compounds of formula I are valuable pharmacologically active compounds. They exhibit a strong antithrombotic effect and are suitable, for example, for the therapy and prophylaxis of cardiovascular disorders like thromboembolic diseases or restenoses. They are reversible inhibitors of the blood clotting enzymes factor Xa (FXa) and/or factor VIIa (FVIIa), and can in general be applied in conditions in which an undesired activity of factor Xa and/or factor VIIa is present or for the cure or prevention of which an inhibition of factor Xa and/or factor VIIa is indicated. The invention furthermore relates to processes for the preparation of compounds of formula I, their use, in particular as pharmaceuticals for treating the foregoing conditions, and pharmaceutical preparations comprising them.

  本发明涉及具有式I的化合物，其中R0；R1；R2；R3；R4；R5；R6；R7；Q；V，G和M具有索赔中指示的含义。式I的化合物是有价值的药理活性化合物。它们表现出强烈的抗血栓作用，例如，适用于治疗和预防心血管疾病如血栓栓塞疾病或再狭窄。它们是血凝酶因子Xa（FXa）和/或因子VIIa（FVIIa）的可逆抑制剂，通常可应用于存在因子Xa和/或因子VIIa不良活性的情况，或者在其治疗或预防需要抑制因子Xa和/或因子VIIa的情况下。此外，本发明还涉及制备式I化合物的方法，它们的用途，特别是作为用于治疗上述疾病的药物，以及包含它们的制剂。